SPDR MSCI Europe UCITS ETF (ETR: SPYE)
Germany
· Delayed Price · Currency is EUR | Assets | 253.82M |
| Expense Ratio | 0.25% |
| PE Ratio | 17.14 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +10.25% |
| Volume | 131 |
| Open | 311.20 |
| Previous Close | 309.55 |
| Day's Range | 310.80 - 311.20 |
| 52-Week Low | 276.50 |
| 52-Week High | 319.95 |
| Beta | 0.79 |
| Holdings | 414 |
| Inception Date | Dec 5, 2014 |
About SPYE
SPDR MSCI Europe UCITS ETF is an exchange traded fund launched and managed by State Street Global Advisors Limited. It is co-managed by State Street Global Advisors France S.A. The fund invests in the public equity markets of developed countries in Europe. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap and mid-cap companies. It seeks to replicate the performance of the MSCI Europe Index, by investing in the stocks of companies as per their weightings in the index. The fund was formerly known as SPDR ETFs - SPDR MSCI Europe UCITS ETF. SPDR MSCI Europe UCITS ETF was formed on May 10, 2001 and is domiciled in Ireland.
Performance
SPYE had a total return of 10.25% in the past year. Since the fund's inception, the average annual return has been 7.61%, including dividends.
Top 10 Holdings
20.95% of assets| Name | Symbol | Weight |
|---|---|---|
| ASML Holding N.V. | ASML | 2.70% |
| Novo Nordisk A/S | NOVO.B | 2.69% |
| SAP SE | SAP | 2.45% |
| Nestlé S.A. | NESN | 2.07% |
| AstraZeneca PLC | AZN | 1.97% |
| Roche Holding AG | ROG | 1.91% |
| Novartis AG | NOVN | 1.86% |
| Shell plc | SHEL | 1.85% |
| LVMH Moët Hennessy - Louis Vuitton, Société Européenne | MC | 1.74% |
| HSBC Holdings plc | HSBA | 1.72% |